BCDA BioCardia Inc

Price (delayed)

$3.43

Market cap

$56.04M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.48

Enterprise value

$35.25M

Sector: Healthcare
Industry: Biotechnology

Highlights

BCDA's quick ratio has soared by 167% from the previous quarter
BCDA's gross margin has soared by 96% YoY and by 12% from the previous quarter
BioCardia's net income has increased by 3.3% from the previous quarter but it has decreased by 2% YoY
BioCardia's revenue has plunged by 80% YoY and by 54% from the previous quarter
BioCardia's gross profit has plunged by 60% YoY and by 48% from the previous quarter

Key stats

What are the main financial stats of BCDA
Market
Shares outstanding
16.34M
Market cap
$56.04M
Enterprise value
$35.25M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.22
Price to sales (P/S)
239.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
243.1
Earnings
Revenue
$145,000
EBIT
-$15M
EBITDA
-$14.44M
Free cash flow
-$12.39M
Per share
EPS
-$1.48
Free cash flow per share
-$1.22
Book value per share
$1.54
Revenue per share
$0.01
TBVPS
$2.31
Balance sheet
Total assets
$23.42M
Total liabilities
$4.25M
Debt
$614,000
Equity
$19.18M
Working capital
$18.41M
Liquidity
Debt to equity
0.03
Current ratio
5.33
Quick ratio
5.24
Net debt/EBITDA
1.44
Margins
EBITDA margin
-9,955.2%
Gross margin
97.2%
Net margin
-10,347.6%
Operating margin
-10,709.7%
Efficiency
Return on assets
-119%
Return on equity
-204.9%
Return on invested capital
N/A
Return on capital employed
-78.2%
Return on sales
-10,345.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BCDA stock price

How has the BioCardia stock price performed over time
Intraday
3.31%
1 week
-0.58%
1 month
-16.14%
1 year
-16.14%
YTD
-0.87%
QTD
-20.97%

Financial performance

How have BioCardia's revenue and profit performed over time
Revenue
$145,000
Gross profit
$141,000
Operating income
-$15.53M
Net income
-$15M
Gross margin
97.2%
Net margin
-10,347.6%
BioCardia's operating margin has shrunk by 116% QoQ
The net margin has dropped by 109% since the previous quarter
BCDA's gross margin has soared by 96% YoY and by 12% from the previous quarter
BioCardia's revenue has plunged by 80% YoY and by 54% from the previous quarter

Growth

What is BioCardia's growth rate over time

Valuation

What is BioCardia stock price valuation
P/E
N/A
P/B
2.22
P/S
239.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
243.1
The EPS has grown by 43% YoY and by 23% from the previous quarter
BCDA's P/B is 84% below its 5-year quarterly average of 13.2
BCDA's P/S is 123% above its last 4 quarters average of 103.8 and 52% above its 5-year quarterly average of 152.5
BioCardia's revenue has plunged by 80% YoY and by 54% from the previous quarter

Efficiency

How efficient is BioCardia business performance
The ROS has plunged by 109% from the previous quarter
The company's return on equity has surged by 79% YoY and by 59% QoQ
The ROA has grown by 47% YoY and by 33% from the previous quarter

Dividends

What is BCDA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BCDA.

Financial health

How did BioCardia financials performed over time
BCDA's current ratio has soared by 168% QoQ
BCDA's quick ratio has soared by 167% from the previous quarter
The debt is 97% smaller than the equity
BioCardia's debt to equity has plunged by 94% YoY and by 90% from the previous quarter
The debt has dropped by 51% since the previous quarter and by 46% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.